Bypassing pluripotency: The promise of direct differentiation from reaggregated micro-fat into multilineage organoids

Organoid technologies have emerged as powerful tools in regenerative medicine; however, current organoid technologies are predominantly based on pluripotent stem cell–derived systems, which poses challenges related to complexity, maturation, and clinical translation. In this commentary, we highlight a recent study by Huang et al. describing a tissue-level strategy for direct generation of functional multilineage organoids from human adult adipose tissue using reaggregated micro-fat (RMF). By preserving native tissue architecture and cellular heterogeneity, this approach enables the formation of mesoderm-, endoderm-, and ectoderm-derived organoids without genetic reprogramming or prolonged expansion culture. RMF-derived organoids demonstrate functional properties in vivo, including support of hematopoiesis and restoration of glycemic control in disease models. While further optimization and standardization will be required for clinical translation, this work provides a compelling alternative to conventional pluripotent stem cell–based paradigms and underscores the importance of tissue context in regenerative strategies. The study reframes adipose tissue as an integrated regenerative substrate and broadens the conceptual landscape of organoid generation toward more clinically accessible approaches.

Authors

Institutions

Publication Details

Journal
Regenerative Therapy
Published
2026-06-27
DOI
https://doi.org/10.1016/j.reth.2026.101158
Primary Topic
Pluripotent Stem Cells Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bypassing pluripotency: The promise of direct differentiation from reaggregated micro-fat into multilineage organoids

Eiji Kobayashi, Koichiro Iohara, Zhi Qi Lum
Regenerative Therapy
Pluripotent Stem Cells Research
article

Bypassing pluripotency: The promise of direct differentiation from reaggregated micro-fat into multilineage organoids

Eiji Kobayashi, Koichiro Iohara, Zhi Qi Lum
article en

Abstract

Organoid technologies have emerged as powerful tools in regenerative medicine; however, current organoid technologies are predominantly based on pluripotent stem cell–derived systems, which poses challenges related to complexity, maturation, and clinical translation. In this commentary, we highlight a recent study by Huang et al. describing a tissue-level strategy for direct generation of functional multilineage organoids from human adult adipose tissue using reaggregated micro-fat (RMF). By preserving native tissue architecture and cellular heterogeneity, this approach enables the formation of mesoderm-, endoderm-, and ectoderm-derived organoids without genetic reprogramming or prolonged expansion culture. RMF-derived organoids demonstrate functional properties in vivo, including support of hematopoiesis and restoration of glycemic control in disease models. While further optimization and standardization will be required for clinical translation, this work provides a compelling alternative to conventional pluripotent stem cell–based paradigms and underscores the importance of tissue context in regenerative strategies. The study reframes adipose tissue as an integrated regenerative substrate and broadens the conceptual landscape of organoid generation toward more clinically accessible approaches.

Regenerative TherapyVol. 33
KAN Research Institute (JP)
Zero hunger
Openalex Percentile: Top 10%
Pluripotent Stem Cells Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.